CTT Pharmaceutical CEO Ryan Khouri acquires 3,400 common shares for $187

CTTH•2026-09-28

CEO Ryan Khouri purchased 3,400 CTT Pharmaceutical shares on the open market at $0.055 each, for $187. His direct holdings rose to 9.43 million shares.

1. Purchase details

A filing lists Khouri as a director and CEO and reports the open-market purchase of 3,400 shares at $0.055 each.

Sources

CTT Pharmaceutical CEO Ryan Khouri acquires 3,400 common shares for $187

Sec

CTT Pharmaceutical CEO Ryan Khouri acquires 3,400 common shares for $187

1. Purchase details

Related News

IDEX schedules third-quarter earnings call and webcast

Worthington Enterprises 10% owner John P. McConnell disposes of common shares worth $4,164,254.66

Nasdaq trading halt: volatility pause at 10:36 a.m.

Sources

CTT Pharmaceutical CEO Ryan Khouri acquires 3,400 common shares for $187

Nasdaq halts XHLD for volatility at 10:42 a.m.

Beco Capital leads Amaani’s $5 million Series A round for AÏZA beauty brand